D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$439M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$391M |
| 3 |
Chevron
CVX
|
+$368M |
| 4 |
Williams Companies
WMB
|
+$334M |
| 5 |
Schlumberger
SLB
|
+$255M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$469M |
| 2 |
Meta Platforms (Facebook)
META
|
+$376M |
| 3 |
Biogen
BIIB
|
+$308M |
| 4 |
Netflix
NFLX
|
+$307M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| 1 | Energy | 14.62% |
| 2 | Technology | 12.08% |
| 3 | Healthcare | 11.47% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Griffon
GFF
$3.68B
| $3.03M | ﹤0.01% |
190,593
-8,601
| -4% | -$137K |
|
1227
Synchrony
SYF
$28.1B
| $3.02M | ﹤0.01% |
91,829
+13,948
| +18% | +$459K |
|
|
OTIC
1228
DELISTED
Otonomy, Inc.
OTIC
| $3.01M | ﹤0.01% |
130,963
-27,914
| -18% | -$642K |
|
|
SNOW
1229
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $3.01M | ﹤0.01% |
258,769
+173,491
| +203% | +$2.02M |
|
|
GCAP
1230
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3M | ﹤0.01% |
314,080
+45,338
| +17% | +$433K |
|
|
FUR
1231
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
| $3M | ﹤0.01% |
198,205
+39,794
| +25% | +$603K |
|
|
ABMD
1232
DELISTED
Abiomed Inc
ABMD
| $3M | ﹤0.01% |
45,600
-435,851
| -91% | -$28.6M |
|
|
SSRI
1233
DELISTED
Silver Standard Resources
SSRI
| $3M | ﹤0.01% |
477,274
+59,618
| +14% | +$374K |
|
1234
Texas Capital Bancshares
TCBI
$3.96B
| $2.99M | ﹤0.01% |
47,948
+38,648
| +416% | +$2.41M |
|
|
FMBI
1235
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $2.98M | ﹤0.01% |
+157,254
| New | +$2.98M |
|
|
PRE
1236
DELISTED
PARTNERRE LTD
PRE
| $2.98M | ﹤0.01% |
23,213
-118,203
| -84% | -$15.2M |
|
|
HA
1237
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.98M | ﹤0.01% |
125,245
+46,619
| +59% | +$1.11M |
|
1238
Broadridge
BR
$29.7B
| $2.97M | ﹤0.01% |
59,285
-125,122
| -68% | -$6.26M |
|
1239
LXP Industrial Trust
LXP
$2.72B
| $2.96M | ﹤0.01% |
349,458
+252,684
| +261% | +$2.14M |
|
1240
Jack Henry & Associates
JKHY
$11.7B
| $2.96M | ﹤0.01% |
45,775
+15,633
| +52% | +$1.01M |
|
1241
TransAlta
TAC
$3.73B
| $2.95M | ﹤0.01% |
380,517
-35,032
| -8% | -$271K |
|
1242
Vanda Pharmaceuticals
VNDA
$268M
| $2.95M | ﹤0.01% |
232,062
-120,719
| -34% | -$1.53M |
|
1243
InterContinental Hotels
IHG
$18.6B
| $2.94M | ﹤0.01% |
55,127
+1,684
| +3% | +$89.9K |
|
|
IRC
1244
DELISTED
INLAND REAL ESTATE CORP
IRC
| $2.94M | ﹤0.01% |
311,762
+51,285
| +20% | +$483K |
|
1245
CACI
CACI
$10.8B
| $2.94M | ﹤0.01% |
36,297
-19,429
| -35% | -$1.57M |
|
1246
National CineMedia
NCMI
$439M
| $2.94M | ﹤0.01% |
18,393
-2,154
| -10% | -$344K |
|
|
DCM
1247
DELISTED
NTT DOCOMO, Inc.
DCM
| $2.94M | ﹤0.01% |
153,432
+99,655
| +185% | +$1.91M |
|
1248
TriMas Corp
TRS
$1.59B
| $2.93M | ﹤0.01% |
124,335
+48,997
| +65% | +$1.16M |
|
|
CARB
1249
DELISTED
Carbonite Inc
CARB
| $2.93M | ﹤0.01% |
248,059
+90,517
| +57% | +$1.07M |
|
|
VIVO
1250
DELISTED
Meridian Bioscience Inc
VIVO
| $2.93M | ﹤0.01% |
156,995
+27,340
| +21% | +$510K |
|